NO962212L - Inflammatorisk cytokinproduksjonsinhibitor inneholdende polyprenylderivater som aktiv bestanddel - Google Patents
Inflammatorisk cytokinproduksjonsinhibitor inneholdende polyprenylderivater som aktiv bestanddelInfo
- Publication number
- NO962212L NO962212L NO962212A NO962212A NO962212L NO 962212 L NO962212 L NO 962212L NO 962212 A NO962212 A NO 962212A NO 962212 A NO962212 A NO 962212A NO 962212 L NO962212 L NO 962212L
- Authority
- NO
- Norway
- Prior art keywords
- cytokine production
- inflammatory cytokine
- production inhibitor
- active ingredient
- inhibitor containing
- Prior art date
Links
- 230000002757 inflammatory effect Effects 0.000 title abstract 6
- 230000016396 cytokine production Effects 0.000 title abstract 4
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 239000004480 active ingredient Substances 0.000 title abstract 2
- 125000001185 polyprenyl group Polymers 0.000 title abstract 2
- 208000009137 Behcet syndrome Diseases 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 208000028774 intestinal disease Diseases 0.000 abstract 2
- 206010009900 Colitis ulcerative Diseases 0.000 abstract 1
- 208000011231 Crohn disease Diseases 0.000 abstract 1
- 201000006704 Ulcerative Colitis Diseases 0.000 abstract 1
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP30075193 | 1993-12-01 | ||
| PCT/JP1994/001971 WO1995015159A1 (en) | 1993-12-01 | 1994-11-22 | Inflammatory cytokine production inhibitor containing polyprenyl derivative as active ingredient |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO962212D0 NO962212D0 (no) | 1996-05-30 |
| NO962212L true NO962212L (no) | 1996-07-31 |
Family
ID=17888662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO962212A NO962212L (no) | 1993-12-01 | 1996-05-30 | Inflammatorisk cytokinproduksjonsinhibitor inneholdende polyprenylderivater som aktiv bestanddel |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US5708037A (cs) |
| EP (1) | EP0806204A4 (cs) |
| KR (1) | KR960706333A (cs) |
| CN (1) | CN1142765A (cs) |
| AU (1) | AU683112B2 (cs) |
| CA (1) | CA2177966A1 (cs) |
| CZ (1) | CZ282294B6 (cs) |
| FI (1) | FI962264A7 (cs) |
| HU (1) | HUT74983A (cs) |
| NO (1) | NO962212L (cs) |
| NZ (1) | NZ276178A (cs) |
| RU (1) | RU2141318C1 (cs) |
| WO (1) | WO1995015159A1 (cs) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH11180873A (ja) * | 1997-12-22 | 1999-07-06 | Kaken Shoyaku Kk | ＮＦ−κＢ活性阻害剤 |
| US20040022787A1 (en) | 2000-07-03 | 2004-02-05 | Robert Cohen | Methods for treating an autoimmune disease using a soluble CTLA4 molecule and a DMARD or NSAID |
| HU226847B1 (en) * | 2000-07-03 | 2009-12-28 | Bristol Myers Squibb Co | Use of soluble ctla4 molecules for treating of rheumatoid arthritis |
| KR100448488B1 (ko) * | 2001-09-03 | 2004-09-13 | (주)프로테옴텍 | 베체트병의 질병 표시인자로서의 아포리포프로테인에이-1을 이용한 진단 시스템 |
| AU2003234594B2 (en) * | 2002-05-17 | 2009-04-02 | Gen-Probe Incorporated | sample carrier having releasable locking mechanism |
| RU2251694C2 (ru) * | 2003-04-30 | 2005-05-10 | Российский НИИ геронтологии Минздрава РФ | Способ дифференциальной диагностики язвенного колита и болезни крона |
| MD480Z5 (ro) * | 2011-07-07 | 2012-09-30 | Эльвира АНДОН | Metodă de tratament al colitei ulceroase nespecifice acute |
| CN108358788A (zh) * | 2017-02-04 | 2018-08-03 | 周厚广 | 有机物对映体纯oa及其在制备ⅱ型糖尿病及血管并发症药物中的用途 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4192953A (en) * | 1975-11-18 | 1980-03-11 | Sankyo Company Limited | Polyprenyl derivatives |
| US4059641A (en) * | 1975-11-18 | 1977-11-22 | Sankyo Company Limited | Polyprenyl derivatives |
| JPS57154123A (en) * | 1981-03-17 | 1982-09-22 | Sankyo Co Ltd | Remedial promotor for wound |
| US4927815A (en) * | 1988-04-29 | 1990-05-22 | Wisconsin Alumni Research Foundation | Compounds effective in inducing cell differentiation and process for preparing same |
-
1994
- 1994-11-22 CZ CZ961566A patent/CZ282294B6/cs not_active IP Right Cessation
- 1994-11-22 HU HU9601460A patent/HUT74983A/hu unknown
- 1994-11-22 AU AU10346/95A patent/AU683112B2/en not_active Ceased
- 1994-11-22 WO PCT/JP1994/001971 patent/WO1995015159A1/ja not_active Application Discontinuation
- 1994-11-22 KR KR1019960702851A patent/KR960706333A/ko not_active Ceased
- 1994-11-22 NZ NZ276178A patent/NZ276178A/xx unknown
- 1994-11-22 RU RU96115259A patent/RU2141318C1/ru active
- 1994-11-22 CA CA002177966A patent/CA2177966A1/en not_active Abandoned
- 1994-11-22 CN CN94194936A patent/CN1142765A/zh active Pending
- 1994-11-22 EP EP95900931A patent/EP0806204A4/en not_active Withdrawn
-
1996
- 1996-05-30 NO NO962212A patent/NO962212L/no not_active Application Discontinuation
- 1996-05-30 FI FI962264A patent/FI962264A7/fi unknown
- 1996-05-31 US US08/656,576 patent/US5708037A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1142765A (zh) | 1997-02-12 |
| AU1034695A (en) | 1995-06-19 |
| EP0806204A4 (en) | 2001-06-27 |
| CZ156696A3 (en) | 1997-01-15 |
| FI962264A0 (fi) | 1996-05-30 |
| AU683112B2 (en) | 1997-10-30 |
| WO1995015159A1 (en) | 1995-06-08 |
| CZ282294B6 (cs) | 1997-06-11 |
| EP0806204A1 (en) | 1997-11-12 |
| NZ276178A (en) | 1997-08-22 |
| NO962212D0 (no) | 1996-05-30 |
| CA2177966A1 (en) | 1995-06-08 |
| FI962264A7 (fi) | 1996-07-05 |
| US5708037A (en) | 1998-01-13 |
| KR960706333A (ko) | 1996-12-09 |
| RU2141318C1 (ru) | 1999-11-20 |
| HUT74983A (en) | 1997-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE164588T1 (de) | Triterpenderivat | |
| RS50035B (sr) | Farmaceutska kompozicija koja sadrži fenofibrat i postupak za njeno dobijanje | |
| NO944928L (no) | Fremgangsmåter for inhibering av Alzheimers sykdom | |
| NO922940L (no) | Fem-leddete heterocykliske forbindelser, fremgangsmaate for deres fremstilling og legemidler inneholdende dem | |
| NO944911L (no) | Ikke-peptid-takykininreseptorantagonister | |
| ATE408593T1 (de) | Pyruvatderivate | |
| NO934501L (no) | Karboksylsyrederivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling | |
| NO944919L (no) | Fremgangsmåte for å inhibere atrofi av huden eller vagina | |
| NO2017045I1 (no) | Farmasøøytisk preparat inneholdende 2-(2-nitro-4-ifluormetylbenzoyl)-1,3-cykloheksandion eller et farmasøytisk godtagbart salt derav | |
| DE69133348D1 (de) | Behandlung von nicht-entzündlichen darmerkrankungen | |
| ATE221073T1 (de) | Neue iridoidderivate und neovaskularisations- inhibitoren die diese als aktviven inhaltstoff enthalten | |
| ES480605A1 (es) | Procedimiento para la obtencion de derivados o-sustituidos del (mas)-cianidanol-3. | |
| NO962212L (no) | Inflammatorisk cytokinproduksjonsinhibitor inneholdende polyprenylderivater som aktiv bestanddel | |
| NO944914L (no) | Fremgangsmåte for å inhibere autoimmunsykdommer | |
| ES2156120T3 (es) | Derivados arilamidicos. | |
| NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
| NO944931L (no) | Anvendelse av 2-fenyl-3-aroylbenzotiofener for inhibering av tidlig seksuell modenhet | |
| MX9306680A (es) | Compuestos de piridil-, quinolil- y naftilmetoxifenilo que inhiben la enzima lipoxigenasa y composiciones farmaceuticas que los contienen. | |
| ATE260109T1 (de) | Darmentzündungen vorbeugendes und therapeutisches arzneimittel | |
| EE04044B1 (et) | Farmatseutilised tooted veresoonte endoteelirakkude kahjustuste tagajärjel tekkinud haiguste raviksja vältimiseks | |
| KR890009389A (ko) | 바이러스를 억제시키는 방법 | |
| AR007052A1 (es) | Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende | |
| MX9203567A (es) | Derivado de monocolin, procedimiento para su preparacion y medicamento que contiene este derivado. | |
| MX9300203A (es) | Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene. | |
| MX9300205A (es) | Compuestos policiclicos disubstituidos y composicion farmaceutica que los contiene. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |